Inhibition of Growth of Keratinocytes by AMPK Activation

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		06-26
IP Type:		Licensable Technology
Title:		Inhibition of Growth of Keratinocytes by AMPK Activation
Inventor:		Holick, Michael F
Summary:		Use of AMP-activated protein kinase (AMPK) activators to inhibit growth of keratinocytes. Useful for treatment of hyperproliferative diseases such as psoriasis and skin cancer.
Tech Type:		Therapeutics - Drugs
URL:		http://ctf-fmfe.bu.edu/BU0626.pdf
Contact:		Rick T. Clark, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Holick, Michael F
Display all intellectual properties for Boston University